Drugs that block CRISPR-Cas9 genome editing identified

The discovery of the first small-molecule inhibitors of the Streptococcus pyogenes Cas9 (SpCas9) protein could enable more precise control over CRISPR-Cas9-based genome editing, researchers report.

Leave a Reply

Your email address will not be published. Required fields are marked *